PUBLISHED DATE : Feb 2020 | Pages : 284
Fill out your details & get your free sample
Transplant Diagnostics Market Size, Share, & Trends Analysis Report by Product (Instruments & Software and Consumables & Test Kits), Application (Diagnostic and Research), Technology (Molecular and Non-Molecular), Transplantation Type (Solid Organ and Soft Tissue), End-Users (Standard Reference Laboratories, Hospitals & Transplant Centers, and Research & Academic Institutes), and Geography (Europe, North America, APAC, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025
284 Pages
37 Tables
178 Charts
5 Regions
18 Countries
14 Companies
6 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (REVENUE) | USD 1.7 BILLION (2025) |
| CAGR | 6% (2020 - 2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segments | Product (Instruments & Software and Consumables & Test Kits), Application (Diagnostic and Research), Technology (Molecular and Non-Molecular), Transplantation Type (Solid Organ and Soft Tissue), End-Users (Standard Reference Laboratories, Hospitals & Transplant Centers, and Research & Academic Institutes) |
| Geographic Analysis | Europe, North America, APAC, Latin America, and Middle East & Africa |
| Countries Covered | Spain, France, Germany, UK, Italy, Canada, US, China, Japan, South Korea, India, Australia, Brazil, Argentina, Mexico, Saudi Arabia, Iran, South Africa, and Israel |
The transplant diagnostics market size to cross USD 1.7 billion by 2025, growing at a CAGR of 6% during the forecast period. The global transplant diagnostics market is growing at a steady rate, which is expected to continue during the forecast period. The high demand for molecular diagnostic tests and the availability of technologically advanced devices with favorable patient demographics are mainly contributing to the high demand for transplant diagnostics devices. Ongoing technological advancements and innovations witnessed in the development of new genomic, transcriptomic, and proteomic biomarkers, especially in the molecular segment, can provide personalized management for transplantation and can detect rejection episodes and infections early, thereby improving the patient outcomes and success rate.
This research report includes detailed segmentation by
The increasing usage of a wide array of reagents and test kits to perform transplant diagnostics tests is a significant factor affecting the growth of the reagents & consumables product segment. The segment is growing at a faster rate than the instruments & software product segment due to their recurring purchase by end-users for performing molecular and non-molecular transplant tests.
The instruments and software segment is growing due to the rise in organ and tissue transplantations and the adoption of advanced techniques. The segment is growing at a relatively slow pace than the consumables & test kits segment as it is capital intensive, and purchasing decisions for these equipment depend on financial resources and budget allocations.
The research application segment is likely to witness faster growth than the clinical application segment as the number of research activities and clinical trials related to transplantation, especially stem cells, is increasing worldwide. The increase in the number of clinical trials and ongoing research activities to improve clinical outcomes is encouraging end-users to effectively screen donors and recipients, perform compatibility assessments and diagnose complications such as organ rejection and infections using molecular and non-molecular tests.
The diagnostics applications segment is growing at a healthy rate and is expected to grow during the forecast period. Transplantation is the treatment of choice for several patients with end-stage organ failure diseases. Significant signs of progress have been achieved both in short-term outcomes and long-term graft survival due to the increasing availability of molecular and serological-based tests to monitor transplant patients. Hence, technological improvements have further increased the application of the segment.
The growing number of solid organ and stem cell replacement, advances in organ transplantation, increase in funding and research grants, and improved public-private investments, and the shift from serological-based tests to gene-based HLA profiling are major factors contributing the growth of the segment. The segment is growing at a faster rate with a CAGR of 8% during the forecast period. The growing adoption of molecular-based techniques in transplantations with the wide availability of PCR and sequence-based products is contributing to the growth of the segment.
In 2019, the non-molecular technology segment accounted for a 38% share of the global transplant diagnostics market. Non-molecular tests have also been contributing sizeable revenues to the global transplant diagnostics market. Several vendors are offering non-molecular testing products, which is further contributing to the growth.
The solid organ transplantation market segment accounted for a 58% share of the global transplant diagnostics market. Solid-organ transplantation has become vital in treating patients suffering from terminal illnesses. Therefore, the global number of solid organ transplantations is increasing at a healthy rate despite interruptions in the organ donation supply mechanism. Incidences of end-stage organ failures are high among patients with chronic diseases, thereby increasing the need for solid organ transplantations. The growth in hematological cancer cases is a key factor for the increasing demand for stem cell therapy worldwide.
Standard reference laboratories conduct tests to identify donor receiver compatibility pre-transplantation. As the number of organs, cells, and tissue replacements is growing worldwide, the demand for laboratory testing is likely to rise at a steady rate. Government financial support for these laboratories is another major factor for the growth of the segment.
Hospitals & transplant centers accounted for a 37% share of the global transplant diagnostics market in 2019. Healthcare professionals in hospitals and transplant centers use various instruments, accessories, and software for conducting pre and post-transplantation diagnostics tests. The market is growing at a healthy rate due to the adoption of advanced instruments accessories and software for organs, cells, and tissue transplantations. The availability of skilled healthcare professionals to perform diagnostics tests also attracts more patients to hospitals and transplant centers. Also, favorable reimbursement for transplant diagnostics is another factor boosting the end-user segment.
North America is the major revenue contributor to the global transplant diagnostics market followed by Europe, APAC, Latin America, and MEA. The region contributed a share of 42% in the year 2019. North America is considered as an attractive market for transplant diagnostics due to high healthcare expenditure in the region.
The transplant diagnostics market in Europe is the second-largest market and accounted for 31% share of the global market. France, the UK, Spain, Germany, and Italy are the major revenue contributors to the Europe market. The APAC region has the largest population density and the highest proportion of various chronic diseases. China is the major revenue contributor in APAC.
Brazil, Mexico, and Argentina are the major revenue contributors to the market in Latin America. The market in Brazil is driven by the increasing chronic disease population, which is leading to the demand for advanced medical treatment options for organ and tissue transplantations. However, the Latin American market is confronted with the unique challenge of infectious disease diagnostics. MEA accounts for the lowest share of the market. The small share can be attributed to poor deceased-donor transplantations in several MEA countries.
The global transplant diagnostics market is moderately competitive and characterized by the presence of a few players offering these products. It is consolidated with a few players accounting for around 75% of the overall market in 2019. The market is witnessing rapid technological advancements, especially in the molecular diagnostics segment. Moreover, key players are witnessing increased competition from various regional and local players globally.
Segmentation by Product
By End-user
By Transplant Type
By Technology
By Application
By Geography
Frequently Asked Questions
What is the market size and compound annual growth rate of the transplant diagnostics market?
The transplant diagnostics market size is expected to reach revenues of $1.7 billion, growing at a CAGR of 6% during 2019-2025.
The availability of skilled healthcare professionals to perform diagnostics tests also attracts more patients to hospitals and transplant centers.
What is the growth of the molecular and non-molecular segment market shares by 2025?
In 2019, the non-molecular technology segment accounted for a 38% share of the global transplant diagnostics market.
Who are the major key players in the transplant diagnostics market and what are their market shares?
The key players in the transplant diagnostics market are Thermo Fisher Scientific, Hoffmann-La Roche, bioMérieux, Bio-Rad Laboratories, QIAGEN, and Immucor. It is consolidated with a few players accounting for around 75% of the overall market in 2019.
The APAC region has the largest population density and the highest proportion of various chronic diseases. China is the major revenue contributor in APAC.
The following factors are likely to contribute to the growth of the transplant diagnostics market during the forecast period:
Base Year: 2019
Forecast Year: 2021–2025
The study considers the present scenario of the global transplant diagnostics market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Other Vendors
Market Segmentation by Product
Market Segmentation by End-user
Market Segmentation by Transplant Type
Market Segmentation by Technology
Market Segmentation by Application
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Applications
4.4.3 Market Segmentation by Technology
4.4.4 Market Segmentation by Transplantation
4.4.5 Market Segmentation by End-users
4.4.6 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Transplant Diagnostics: Overview
7.1.1 Background
7.1.2 Role of Diagnostics in Transplantations
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increasing Number of Transplantations & Prevalence of Chronic Diseases
8.1.2 Rising Incidence of Infections Caused by Transplantations
8.1.3 Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients
8.1.4 Technological Advancements in Transplant Diagnostics
8.2 Market Growth Restraints
8.2.1 Increasing Gap Between Number of Organ Donors & Recipients
8.2.2 Ethical Challenges Related to Organ Procurement and Transplantation
8.2.3 High Costs Associated with Transplant Diagnostics
8.3 Market Opportunities and Trends
8.3.1 Emergence of cfDNA in Transplant Diagnostics
8.3.2 Growing Demand in Emerging Economies
8.3.3 Increasing Focus on Identifying Novel Biomarkers for Minimizing Transplantation Rejection
9 Global Transplant Diagnostics Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Transplant Diagnostics Market by Products
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Consumables & Test Kits
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.4 Instruments & Software
10.4.1 Market Overview
10.4.2 Market Size & Forecast
11 Transplant Diagnostics Market by Applications
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Diagnostic Applications
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Research Applications
11.4.1 Market Overview
11.4.2 Market Size & Forecast
12 Transplant Diagnostics Market by Technology
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Molecular Tests
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Non-molecular
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 Transplant Diagnostics Market by Transplantation
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Solid Organ Transplantation
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Soft Tissue Transplantation
13.4.1 Market Overview
13.4.2 Market Size & Forecast
14 Transplant Diagnostics Market by End-Users
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Standard Reference Laboratories
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Hospitals & Transplant Centers
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Academic Institutes & Research Laboratories
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 Transplant Diagnostics Market by Geography
15.1 Market Snapshot & Growth Engine
15.2 Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 US: Transplant Diagnostics Market Size & Forecast
16.3.2 Canada: Market Size & Forecast
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 France: Transplant Diagnostics Market Size & Forecast
17.3.2 UK: Market Size & Forecast
17.3.3 Spain: Market Size & Forecast
17.3.4 Germany: Market Size & Forecast
17.3.5 Italy: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 China: Transplant Diagnostics Market Size & Forecast
18.3.2 Japan: Market Size & Forecast
18.3.3 India: Market Size & Forecast
18.3.4 South Korea: Market Size & Forecast
18.3.5 Australia: Market Size & Forecast
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Brazil: Transplant Diagnostics Market Size & Forecast
19.3.2 Mexico: Market Size & Forecast
19.3.3 Argentina: Market Size & Forecast
20 Middle East & Africa
20.1 Market Overview
20.2 Key Countries
20.2.1 Saudi Arabia: Transplant Diagnostics Market Size & Forecast
20.2.2 Iran: Market Size & Forecast
20.2.3 South Africa: Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Thermo Fisher Scientific
21.2.2 F. Hoffmann-La Roche
21.2.3 bioMérieux
21.2.4 Bio-Rad Laboratories
21.2.5 QIAGEN
21.2.6 Immucor
22 Key Company Profiles
22.1 Thermo Fisher Scientific
22.1.1 Business Overview
22.1.2 Major Product Offerings
22.1.3 Key Strengths
22.1.4 Key Strategies
22.1.5 Key Opportunities
22.2 F. Hoffmann-La Roche
22.2.1 Business Overview
22.2.2 Major Product Offerings
22.2.3 Key Strengths
22.2.4 Key Strategies
22.2.5 Key Opportunities
22.3 bioMérieux
22.3.1 Business Overview
22.3.2 Major Product Offerings
22.3.3 Key Strengths
22.3.4 Key Strategies
22.3.5 Key Opportunities
22.4 Bio-Rad Laboratories
22.4.1 Business Overview
22.4.2 Major Product Offerings
22.4.3 Key Strengths
22.4.4 Key Strategies
22.4.5 Key Opportunities
22.5 QIAGEN
22.5.1 Business Overview
22.5.2 Major Product Offerings
22.5.3 Key Strengths
22.5.4 Key Strategies
22.5.5 Key Opportunities
22.6 Immucor
22.6.1 Business Overview
22.6.2 Major Product Offerings
22.6.3 Key Strengths
22.6.4 Key Strategies
22.6.5 Key Opportunities
23 Other Prominent Vendors
23.1 BAG Diagnostics
23.1.1 Business Overview
23.1.2 Major Product Offerings
23.2 CareDx
23.2.1 Business Overview
23.2.2 Major Product Offerings
23.2.3 Key Strengths
23.2.4 Key Strategies
23.2.5 Key Opportunities
23.3 ELITechGroup
23.3.1 Business Overview
23.3.2 Major Product Offerings
23.3.3 Key Strengths
23.3.4 Key Strategies
23.3.5 Key Opportunities
23.4 Genome Diagnostics
23.4.1 Business Overview
23.4.2 Major Product Offerings
23.4.3 Key Strengths
23.4.4 Key Strategies
23.4.5 Key Opportunities
23.5 Illumina
23.5.1 Business Overview
23.5.2 Major Product Offerings
23.5.3 Key Strengths
23.5.4 Key Strategies
23.5.5 Key Opportunities
23.6 NanoString Technologies
23.6.1 Business Overview
23.6.2 Major Product Offerings
23.6.3 Key Strengths
23.6.4 Key Strategies
23.6.5 Key Opportunities
23.7 Omixon
23.7.1 Business Overview
23.7.2 Major Product Offerings
23.7.3 Key Strengths
23.7.4 Key Strategies
23.7.5 Key Opportunities
23.8 Transplant Genomics
23.8.1 Business Overview
23.8.2 Major Product Offerings
23.8.3 Key Strengths
23.8.4 Key Strategies
23.8.5 Key Opportunities
23.9 Wakunaga Pharmaceutical
23.9.1 Business Overview
23.9.2 Major Product Offerings
23.9.3 Key Strengths
23.9.4 Key Strategies
23.9.5 Key Opportunities
24 REPORT SUMMARY
24.1 Key Takeaways
24.2 Strategic Recommendations
24.3 Quantitative Summary
24.3.1 By Products
24.3.2 By Applications
24.3.3 By Transplantation
24.3.4 By Technology
24.3.5 By End-users
24.3.6 By Geography
25 Appendix
25.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Transplant Diagnostics Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Impact of Increasing Number of Transplantations & Prevalence of Chronic Diseases
Exhibit 4 Percentage Share of Chronic Conditions in Various Countries
Exhibit 5 Impact of Rising Incidence of Infections Caused by Transplantations
Exhibit 7 Impact of Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients
Exhibit 8 Technological Advancements in Transplant Diagnostics
Exhibit 9 Impact of Increasing Gap Between Number of Organ Donors & Recipients
Exhibit 10 Average Waiting Time for Transplantation Recipients in US 2017 (days)
Exhibit 11 Total Number of Actual Deceased Organ Donors 2013−2018
Exhibit 12 Total Number of Utilized Deceased Organ Donors 2013−2018
Exhibit 13 Gap between Actual and Utilized Deceased Organ Donors 2013−2018
Exhibit 14 Impact of Ethical Challenges Related to Organ Procurement and Transplantation
Exhibit 15 Number of Organ Transplantations in Germany 2013-2017
Exhibit 16 Number of Organ Transplantations in Japan 2014-2017
Exhibit 17 Number of Organ Transplantations in South Africa 2013-2017
Exhibit 18 Impact of High Costs Associated with Transplant Diagnostics
Exhibit 19 Monthly Laboratory Costs Post-transplantation for In-patient Care
Exhibit 20 Monthly Laboratory Costs Post-transplantation for Out-patient Care
Exhibit 21 Impact of Emergence of cfDNA as a Non-invasive Biomarker in Transplant Diagnostics
Exhibit 22 Impact of Growing demand for Transplant Diagnostics in Emerging Economies
Exhibit 23 Incremental Growth of Transplant Diagnostics Market in China
Exhibit 24 Incremental Growth of Transplant Diagnostics Market in India
Exhibit 25 Impact of Increasing Focus on Identifying Novel Biomarkers for Minimizing Transplantation Rejection
Exhibit 26 Global Transplant Diagnostics Market 2019−2025 ($ million)
Exhibit 27 Global Transplant Diagnostics Market by Geography 2019 & 2025 (%)
Exhibit 28 Global Transplant Diagnostics Market by Products 2019 & 2025 (%)
Exhibit 29 Global Transplant Diagnostics Market by Applications 2019 & 2025 (%)
Exhibit 30 Global Transplant Diagnostics Market by Transplantation 2019 & 2025 (%)
Exhibit 31 Global Transplant Diagnostics Market by End-users 2019 & 2025 (%)
Exhibit 32 Global Transplant Diagnostics Market by Technology 2019 & 2025 (%)
Exhibit 33 Five Force Analysis 2019
Exhibit 34 Incremental Growth by Products 2019−2025
Exhibit 35 Global Transplant Diagnostics Market by Products
Exhibit 36 Global Market by Products: Incremental Growth
Exhibit 37 Global Market by Products: Absolute Growth
Exhibit 38 Global Market by Products 2019−2025 ($ million)
Exhibit 39 Global Market by Products 2019−2025 (%)
Exhibit 40 Global Consumables & Test Kits Market: Absolute & Incremental Growth
Exhibit 41 Global Reagents & Consumables Market 2019−2025 ($ million)
Exhibit 42 Global Leukemia Incidence Rate in 2018
Exhibit 43 Global Instruments & Software Market 2019−2025 ($ million)
Exhibit 44 Incremental Growth by Applications 2019-2025
Exhibit 45 Global Transplant Diagnostics Market by Applications
Exhibit 46 Global Market Overview by Applications: Snapshot
Exhibit 47 Global Market by Applications: Incremental Growth
Exhibit 48 Global Market by Applications: Absolute Growth
Exhibit 49 Global Market by Applications 2019−2025 ($ million)
Exhibit 50 Global Market by Applications 2019−2025 (%)
Exhibit 51 Global Market by Diagnostics Applications: Absolute & Incremental Growth
Exhibit 52 Global Market by Diagnostics Applications 2019−2025 ($ million)
Exhibit 53 Global Market by Research Applications: Absolute & Incremental Growth
Exhibit 54 Global Market by Research Applications 2019−2025 ($ million)
Exhibit 55 Incremental Growth by Technology 2019-2025
Exhibit 56 Global Transplant Diagnostics Market by Technology
Exhibit 57 Global Market Segmentation by Technology: Snapshot
Exhibit 58 Global Market by Technology: Incremental Growth
Exhibit 59 Global Market by Technology: Absolute Growth
Exhibit 60 Global Market by Technology 2019−2025 ($ million)
Exhibit 61 Global Market by Technology 2019−2025 (%)
Exhibit 62 Popular PCR-Based Molecular Products Offered by Market Players
Exhibit 63 Popular NGS Products Offered by Few Market Players
Exhibit 64 Global Molecular Transplant Diagnostics Market 2019−2025 ($ million)
Exhibit 65 Global Non-molecular Transplant Diagnostics Market 2019−2025 ($ million)
Exhibit 66 Incremental Growth by Transplantation 2019-2025
Exhibit 67 Global Transplant Diagnostics Market by Transplantation
Exhibit 68 Global Market Segmentation by Transplantation: Snapshot
Exhibit 69 Global Market by Transplantation: Incremental Growth
Exhibit 70 Global Market by Transplantation: Absolute Growth
Exhibit 71 Global Market by Transplantation 2019−2025 ($ million)
Exhibit 72 Global Market by Transplantation 2019−2025 (%)
Exhibit 73 Worldwide Total Kidney Transplantations 2013−2018
Exhibit 74 Worldwide Total Liver Transplantations 2013−2018
Exhibit 75 Worldwide Total Heart Transplantations 2013−2018
Exhibit 76 Worldwide Total Lung Transplantations 2013−2018
Exhibit 77 Global Solid Organ Transplant Diagnostics Market 2019−2025 ($ million)
Exhibit 78 Global Leukemia Incidence in 2018
Exhibit 79 Global Hodgkin Lymphoma Incidence in 2018
Exhibit 80 Global Non-Hodgkin Lymphoma Incidence in 2018
Exhibit 81 Global Soft Tissue Transplant Diagnostics Market 2019−2025 ($ million)
Exhibit 82 Incremental Growth by End-users 2019-2025
Exhibit 83 Global Transplant Diagnostics Market by End-users
Exhibit 84 Global Market by End-users: Incremental Growth
Exhibit 85 Global Market by End-users: Absolute Growth
Exhibit 86 Global Market by End-users 2019−2025 ($ million)
Exhibit 87 Global Market by End-users 2019−2025 (%)
Exhibit 88 Global Market by Standard Reference Laboratories: Absolute & Incremental Growth
Exhibit 89 Global Standard Reference Laboratories Market 2019−2025 ($ million)
Exhibit 90 Global Market by Hospitals & Transplant Centers: Absolute & Incremental Growth
Exhibit 91 Global Hospitals & Transplant Centers Market 2019−2025 ($ million)
Exhibit 92 Market by Academic Institutes & Research Laboratories: Absolute & Incremental Growth
Exhibit 93 Global Academic Institutes & Research Laboratories Market 2019−2025 ($ million)
Exhibit 94 Incremental Growth by Geography 2019-2025
Exhibit 95 Global Transplant Diagnostics Market by Geography
Exhibit 96 Global Market Share by Top Countries 2019
Exhibit 97 Global Market by Geography: Key Countries 2019
Exhibit 98 Global Market by Geography: Absolute Growth
Exhibit 99 Global Market by Geography: Incremental Growth
Exhibit 100 Market in North America 2019
Exhibit 101 North America Market: Absolute & Incremental Growth
Exhibit 102 North America Market 2019−2025 ($ million)
Exhibit 103 Incremental Growth in North America 2019−2025
Exhibit 104 Total Solid Organ Transplantations in the US 2013−2018
Exhibit 105 Tissue Transplantations in the US 2013-2017
Exhibit 106 Market in the US 2019−2025 ($ million)
Exhibit 107 Total Solid Organ Transplantations in Canada 2013−2018
Exhibit 108 Market in Canada 2019−2025
Exhibit 109 Europe Market 2019
Exhibit 110 Europe Market: Absolute & Incremental Growth
Exhibit 111 Incidence of Blood-related Cancers in 2018
Exhibit 112 Market in Europe 2019–2025 ($ million)
Exhibit 113 Incremental Growth in Europe 2019-2025
Exhibit 114 Total Solid Organ Transplantations in France 2013−2018
Exhibit 115 Market in France 2019–2025 ($ million)
Exhibit 116 Total Solid Organ Transplantations in the UK 2013−2018
Exhibit 117 Market in the UK 2019–2025 ($ million)
Exhibit 118 Total Solid Organ transplantations in Spain 2013−2018
Exhibit 119 Market in Spain 2019–2025 ($ million)
Exhibit 120 Total Solid Organ Transplantations in Germany 2013−2018
Exhibit 121 Market in Germany 2019–2025 ($ million)
Exhibit 122 Incidences of Total Blood-related Cancer Cases in Italy 2018
Exhibit 123 Total Solid Organ Transplantations in Italy 2013−2018
Exhibit 124 Market in Italy 2019–2025 ($ million)
Exhibit 125 Total Solid Organ Transplantations in APAC 2013−2018
Exhibit 126 APAC Market 2019
Exhibit 127 APAC Market: Absolute & Incremental Growth
Exhibit 128 Market in APAC 2019−2025 ($ million)
Exhibit 129 Incremental Growth in APAC 2019-2025
Exhibit 130 Total Solid Organ Transplantations in China 2013−2017
Exhibit 131 Total New Blood Cancer Cases in China 2018
Exhibit 132 Market in China 2019–2025 ($ million)
Exhibit 133 Total Solid Organ Transplantations in Japan 2013−2017
Exhibit 134 Annual Number of Bone Marrow Transplant Recipients by Transplant Type in Japan 2013-2017
Exhibit 135 Market in Japan 2019–2025 ($ million)
Exhibit 136 Total Solid Organ transplantations in India 2013−2018
Exhibit 137 Market in India 2019–2025 ($ million)
Exhibit 138 Total Solid Organ Transplantations in South Korea 2013−2018
Exhibit 139 Market in South Korea 2019–2025 ($ million)
Exhibit 140 Total New Blood Cancer Cases in Australia 2018
Exhibit 141 Total Solid Organ Transplantations in Australia 2013−2018
Exhibit 142 Market in Australia 2019–2025 ($ million)
Exhibit 143 Market in Latin America by Key Countries 2019
Exhibit 144 Market in Latin America: Absolute & Incremental Growth
Exhibit 145 Latin America Market 2019−2025 ($ million)
Exhibit 146 Incremental Growth in Latin America 2019-2025
Exhibit 147 Total Solid Organ Transplantations in Brazil 2013−2018
Exhibit 148 New Blood Related Cancer Incidences in Brazil 2018
Exhibit 149 Market in Brazil 2019–2025 ($ million)
Exhibit 150 Total Solid Organ Transplantations in Mexico 2013−2018
Exhibit 151 Market in Mexico 2019–2025 ($ million)
Exhibit 152 Total Solid Organ Transplantations in Argentina 2013−2018
Exhibit 153 Market in Argentina 2019–2025 ($ million)
Exhibit 154 MEA Market 2019
Exhibit 155 MEA Market: Absolute & Incremental Growth
Exhibit 156 Market in MEA 2019–2025 ($ million)
Exhibit 157 Incremental Growth in MEA 2019-2025
Exhibit 158 Total Solid Organ Transplantations in Saudi Arabia 2013−2018
Exhibit 159 Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 160 Market in Iran 2019–2025 ($ million)
Exhibit 161 Total Solid Organ Transplantations in Iran 2013−2016
Exhibit 162 Total Solid Organ Transplantations in South Africa 2013−2017
Exhibit 163 Market in South Africa 2019–2025 ($ million)
Exhibit 164 Global Transplant Diagnostics Market: Vendors Share 2019
Exhibit 165 Thermo Fisher Scientific: R&D Expenditure 2016−2018 ($ million)
Exhibit 166 Thermo Fisher Scientific: Revenue by Business Segments 2017−2018 ($ million)
Exhibit 167 Thermo Fisher Scientific: Revenue by Regions 2017−2018
Exhibit 168 F. Hoffmann-La Roche: R&D Expenditure in 2016−2018 ($ billion)
Exhibit 169 F. Hoffmann-La Roche: Revenue by Business Segments in 2017−2018 ($ billion)
Exhibit 170 F. Hoffmann-La Roche: Revenue by Geography ($ billion)
Exhibit 171 bioMérieux: R&D Expenditure 2016−2018 ($ million)
Exhibit 172 bioMérieux: Revenue by Applications 2017−2018 ($ million)
Exhibit 173 bioMérieux: Revenue by Geography 2018
Exhibit 174 Bio-Rad Laboratories: Revenue by Segments 2017 & 2018 ($ million)
Exhibit 175 Bio-Rad Laboratories: Revenue by Geography 2018
Exhibit 176 QIAGEN: R&D Expenditure in 2016−2018 ($ million)
Exhibit 177 QIAGEN: Revenue by Business Segments in 2017−2018
Exhibit 178 QIAGEN: Revenue by Geography in 2018
Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2014−2019
Table 3 Comparison of Serological and Molecular Assays
Table 4 Capital Costs for the Implementation of Next-generation Sequencing
Table 5 Absolute Growth of Transplant Diagnostics in Developed and Emerging Economies (%)
Table 6 List of Consumables & Test Kits from Various Players
Table 7 List of Transplant Diagnostic Instruments & Software from Various Players
Table 8 List of Products Available for Diagnostic Applications of Pre- and Post-transplantations
Table 9 Healthcare Expenditure as Percent of GDP in Major Latin American Countries
Table 10 Global Transplant Diagnostics Market: Top Vendors Ranking
Table 11 Thermo Fisher Scientific: Key Product Offerings
Table 12 F. Hoffmann-La Roche: Key Product Offerings
Table 13 bioMérieux: Key Product Offerings
Table 14 Bio-Rad Laboratories: Key Product Offerings
Table 15 QIAGEN: Key Product Offerings
Table 16 Immucor: Key Product Offerings
Table 17 BAG Diagnostics: Key Product Offerings
Table 18 CareDx: Key Product Offerings
Table 19 ELITechGroup: Key Product Offerings
Table 20 Genome Diagnostics: Key Product Offerings
Table 21 Illumina: Key Product Offerings
Table 22 NanoString Technologies: Key Product Offerings
Table 23 Omixon: Key Product Offerings
Table 24 Transplant Genomics: Key Product Offerings
Table 25 Wakunaga Pharmaceutical: Key Product Offerings
Table 26 Global Transplant Diagnostics Market by Products ($ million)
Table 27 Global Market by Products (%)
Table 28 Global Market by Applications ($ million)
Table 29 Global Market by Applications (%)
Table 30 Global Market by Transplantation ($ million)
Table 31 Global Market by Transplantation (%)
Table 32 Global Market by Technology ($ million)
Table 33 Global Market by Technology (%)
Table 34 Global Market by End-users ($ million)
Table 35 Global Market by End-users (%)
Table 36 Global Market by Geography ($ million)
Table 37 Global Market by Geography (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
